-
Bexarotene Capable of Regenerating Lost Myelin
The MS UK Society reported on 25 Sept that ‘The results from our Phase 2a clinical trial have shown that bexarotene is capable of regenerating lost myelin‘.
Professor Alasdair Coles from the University of Cambridge, who led the research, said: “The lessons we’ve learned are incredibly exciting, as we now have further concrete evidence that remyelination in humans is possible. This discovery gives us confidence that we will stop MS, and will swiftly be taken forward into further studies trialling other potential new myelin repair treatments.”
MSNT carried a report on the beginning of this back in Dec 2017.
Myelin repair is besides a cure the MS golden ticket. Would you consider buying a chocolate bar?
Sorry, there were no replies found.
Log in to reply.